NEXT TRILLION SCIENCES
LIVE

Serial Number

97334275

Owner

NTS Ventures LLC

Attorney

Brian E. Turung

Filing Date

Mar 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEXT TRILLION SCIENCES Trademark

Serial Number: 97334275

NEXT TRILLION SCIENCES is a trademark filed by NTS Ventures LLC on March 28, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

NTS Ventures LLC (11 trademarks)

Suite 4500
Cleveland, OH 44115

Entity Type: 16

Trademark Details

Filing Date

March 28, 2022

Registration Date

Not Registered

Published for Opposition

May 23, 2023

Goods & Services

Hospital services; providing healthcare consulting services in the fields of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; Providing medical information retarding regarding available tests and the review of tests related to the infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; providing medical information about the use of microorganisms to treat diseases and medical conditions in the digestive system; medical diagnosis of diseases and medical conditions in particular digestive disorders, speech disorders, breast cancer, infertility, mental health disorders, autoimmune diseases, learning disabilities;providing medical information, advice and consultation to others in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements

Pre-clinical and clinical testing services for companies, medical professionals, namely, conducting clinical trials for others, consulting services for others in the field of design, planning, and implementation project management of clinical trials; consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses for research purposes in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; providing scientific research information in the field of pre-clinical testing; medical and scientific research, namely, conducting clinical and pre-clinical trial services for others; providing scientific analysis in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements;scientific study and research in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; scientific and technological services, namely, scientific analysis in the field of testing the human body

Pre-clinical and clinical testing services for companies, medical professionals, namely, providing independent review of clinical trials for business purposes, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs

Printed reports, namely, printed scientific analysis and informational reports based upon results of laboratory and clinical testing in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements

Pre-clinical and clinical testing services for companies, medical professionals, namely, providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Filing History

SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 23, 2026 TPEX
NOTICE OF REVIVAL - E-MAILED
Apr 23, 2026 NREV
PETITION TO REVIVE-GRANTED
Apr 23, 2026 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 23, 2026 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 23, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 23, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jul 10, 2025 EX4G
SOU EXTENSION 4 FILED
Jul 10, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 22, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 21, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 21, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 18, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 18, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 17, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 17, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 17, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 11, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2022 NWOS